CGH
PRAH

Crossmark Global Holdings’s PRA Health Sciences, Inc. PRAH Stock Holding History

Crossmark Global Holdings’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-7,828
Closed -$1.29M – 1452
2021
Q2 		$1.29M Sell
7,828
-290
-4% -$48.4K 0.03% 530
2021
Q1 		$1.25M Sell
8,118
-280
-3% -$38K 0.03% 521
2020
Q4 		$1.05M Buy
8,398
+460
+6% +$51.4K 0.03% 561
2020
Q3 		$805K Buy
7,938
+40
+0.5% +$4.08K 0.02% 602
2020
Q2 		$768K Buy
7,898
+568
+8% +$52.9K 0.02% 615
2020
Q1 		$609K Sell
7,330
-40
-0.5% -$3.9K 0.02% 596
2019
Q4 		$819K Sell
7,370
-770
-9% -$79.2K 0.02% 615
2019
Q3 		$808K Sell
8,140
-100
-1% -$9.93K 0.02% 594
2019
Q2 		$817K Sell
8,240
-600
-7% -$57.3K 0.02% 604
2019
Q1 		$975K Buy
8,840
+140
+2% +$14.6K 0.03% 554
2018
Q4 		$800K Buy
8,700
+240
+3% +$24.3K 0.02% 584
2018
Q3 		$932K Buy
8,460
+460
+6% +$47.9K 0.02% 635
2018
Q2 		$747K Buy
+8,000
New +$689K 0.02% 725

Other funds holding PRAH

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Crossmark Global Holdings's PRAH Position: Q3 2021 in Review

Crossmark Global Holdings sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 7,828 shares — an estimated $1.29M sold.

Crossmark Global Holdings first reported a position in PRAH in Q2 2018 and held it in 13 quarters. The position peaked at $1.29M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Crossmark Global Holdings reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Crossmark Global Holdings sold 7,828 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $1.29M.
  • Crossmark Global Holdings first reported a position in PRA Health Sciences, Inc. in Q2 2018 and held it in 13 quarters.
  • Crossmark Global Holdings's PRA Health Sciences, Inc. position peaked at $1.29M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Crossmark Global Holdings's 13F filing for Q3 2021, filed 13 Oct 2021.